These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18236140)

  • 61. Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial.
    Conaghan PG; O'Brien CM; Wilson M; Schofield JP
    Osteoarthritis Cartilage; 2011 Aug; 19(8):930-8. PubMed ID: 21477658
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comment on Koltzenburg et al.: Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine. Pain 2006;126:165-74.
    Angst MS; Clark DJ
    Pain; 2007 Apr; 128(3):292-294. PubMed ID: 17276008
    [No Abstract]   [Full Text] [Related]  

  • 63. Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age.
    Likar R; Vadlau EM; Breschan C; Kager I; Korak-Leiter M; Ziervogel G
    Clin J Pain; 2008; 24(6):536-43. PubMed ID: 18574363
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers.
    Bai SA; Xiang Q; Finn A
    Clin Ther; 2016 Feb; 38(2):358-69. PubMed ID: 26804639
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analgesic treatment with buprenorphine should be adapted to the mouse strain.
    Rudeck J; Vogl S; Heinl C; Steinfath M; Fritzwanker S; Kliewer A; Schulz S; Schönfelder G; Bert B
    Pharmacol Biochem Behav; 2020 Apr; 191():172877. PubMed ID: 32088361
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
    Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
    Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study.
    Karlsson J; Söderström A; Augustini BG; Berggren AC
    Curr Med Res Opin; 2014 Apr; 30(4):575-87. PubMed ID: 24320787
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].
    Böhme K; Heckes B; Thomitzek K
    MMW Fortschr Med; 2011 Jan; 152 Suppl 4():125-32. PubMed ID: 21598463
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transdermal buprenorphine in the treatment of chronic pain.
    Sittl R
    Expert Rev Neurother; 2005 May; 5(3):315-23. PubMed ID: 15938664
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Buprenorphine transdermal patch (Norspan tape)].
    Hamaguchi S; Ikeda T
    Masui; 2013 Jul; 62(7):799-807. PubMed ID: 23905402
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies.
    Louis F
    Int J Clin Pract; 2006 Oct; 60(10):1330-4. PubMed ID: 16981980
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics of buprenorphine after single-dose subcutaneous administration in red-eared sliders (Trachemys scripta elegans).
    Kummrow MS; Tseng F; Hesse L; Court M
    J Zoo Wildl Med; 2008 Dec; 39(4):590-5. PubMed ID: 19110701
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analgesic patches and defibrillators: a cautionary tale.
    Brown MR; Denman R; Platts D
    Europace; 2009 Nov; 11(11):1552-3. PubMed ID: 19801566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain.
    Ruggiero A; Coccia P; Arena R; Maurizi P; Battista A; Ridola V; Attinà G; Riccardi R
    Pediatr Blood Cancer; 2013 Mar; 60(3):433-7. PubMed ID: 23034996
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Use of Transdermal Buprenorphine in Complex Regional Pain Syndrome: A Report of Two Cases.
    Onofrio S; Vartan CM; Nazario M; DiScala S; Cuevas-Trisan R; Melendez-Benabe J
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):124-7. PubMed ID: 27172230
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transdermal buprenorphine.
    Evans HC; Easthope SE
    Drugs; 2003; 63(19):1999-2010; discussion 2011-2. PubMed ID: 12962515
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice.
    Gades NM; Danneman PJ; Wixson SK; Tolley EA
    Contemp Top Lab Anim Sci; 2000 Mar; 39(2):8-13. PubMed ID: 11487232
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain.
    James IG; O'Brien CM; McDonald CJ
    J Pain Symptom Manage; 2010 Aug; 40(2):266-78. PubMed ID: 20541900
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain.
    Correa-Illanes G; Roa RG; B Piñeros JL; Ferrer FT; Adriasola VR
    Pain Manag; 2014 May; 4(3):181-90. PubMed ID: 24835268
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study.
    Gallagher AM; Leighton-Scott J; van Staa TP
    Clin Ther; 2009 Aug; 31(8):1707-15. PubMed ID: 19808129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.